SRPT Sarepta Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SRPT

Price (delayed)

$144.275

Market cap

$13.64B

P/E Ratio

351.89

Dividend/share

N/A

EPS

$0.41

Enterprise value

$14.59B

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going ...

Highlights
The EPS has soared by 107% from the previous quarter and by 103% YoY
The net income has soared by 103% QoQ and by 102% YoY
Sarepta Therapeutics's quick ratio has decreased by 26% YoY and by 8% from the previous quarter
SRPT's debt is up by 7% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: https://www.sarepta.com/
Peers: GILD NVAX PTCT BCRX

Key stats

What are the main financial stats of SRPT
Market
Shares outstanding
94.52M
Market cap
$13.64B
Enterprise value
$14.59B
Valuations
Price to earnings (P/E)
351.89
Price to book (P/B)
14.09
Price to sales (P/S)
9.66
EV/EBIT
428.35
EV/EBITDA
160.1
EV/Sales
10.4
Earnings
Revenue
$1.4B
EBIT
$34.06M
EBITDA
$91.13M
Free cash flow
-$632.74M
Per share
EPS
$0.41
Free cash flow per share
-$6.73
Book value per share
$10.24
Revenue per share
$14.93
TBVPS
$34.31
Balance sheet
Total assets
$3.22B
Total liabilities
$2.26B
Debt
$1.38B
Equity
$961.19M
Working capital
$1.86B
Liquidity
Debt to equity
1.44
Current ratio
4.05
Quick ratio
2.91
Net debt/EBITDA
10.45
Margins
EBITDA margin
6.5%
Gross margin
88.2%
Net margin
1.2%
Operating margin
-6.8%
Efficiency
Return on assets
0.5%
Return on equity
2%
Return on invested capital
1%
Return on capital employed
1.3%
Return on sales
2.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SRPT stock price

How has the Sarepta Therapeutics stock price performed over time
Intraday
-2.23%
1 week
-0.92%
1 month
-8.05%
1 year
38.55%
YTD
49.62%
QTD
-8.69%

Financial performance

How have Sarepta Therapeutics's revenue and profit performed over time
Revenue
$1.4B
Gross profit
$1.24B
Operating income
-$94.83M
Net income
$16.9M
Gross margin
88.2%
Net margin
1.2%
The net income has soared by 103% QoQ and by 102% YoY
SRPT's net margin has surged by 103% since the previous quarter and by 101% year-on-year
SRPT's operating margin has soared by 89% YoY and by 68% from the previous quarter
SRPT's operating income has soared by 84% year-on-year and by 65% since the previous quarter

Growth

What is Sarepta Therapeutics's growth rate over time

Valuation

What is Sarepta Therapeutics stock price valuation
SRPT P/E details
P/E
351.89
P/B
14.09
P/S
9.66
EV/EBIT
428.35
EV/EBITDA
160.1
EV/Sales
10.4
The EPS has soared by 107% from the previous quarter and by 103% YoY
The company's equity rose by 35% YoY and by 12% QoQ
SRPT's P/B is 10% above its last 4 quarters average of 13.1 and 8% above its 5-year quarterly average of 13.3
The revenue rose by 44% YoY and by 13% QoQ
The P/S is 29% less than the 5-year quarterly average of 13.9 but 11% more than the last 4 quarters average of 8.9

Efficiency

How efficient is Sarepta Therapeutics business performance
The ROS has soared by 106% from the previous quarter and by 102% YoY
Sarepta Therapeutics's ROIC has soared by 106% from the previous quarter and by 103% YoY
The ROA has soared by 103% from the previous quarter and by 101% YoY
The return on equity has surged by 103% since the previous quarter and by 101% year-on-year

Dividends

What is SRPT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SRPT.

Financial health

How did Sarepta Therapeutics financials performed over time
The total assets is 42% more than the total liabilities
Sarepta Therapeutics's quick ratio has decreased by 26% YoY and by 8% from the previous quarter
The company's current ratio fell by 13% YoY but it rose by 2.5% QoQ
SRPT's debt is 44% greater than its equity
The company's equity rose by 35% YoY and by 12% QoQ
The debt to equity has declined by 20% year-on-year and by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.